Sustainability Data Hub TM
A pharmaceutical company specializing in developing innovative therapies for various medical conditions, focusing on enhancing treatment options for healthcare professionals.
1946
Germany
51 - 200 employees
Pharmaceuticals
$25M - 100M in revenue
Not profitable
See all
Carbon emissions
Electricity consumption
Carbon certificate projects
Targets
Other sustainability metrics
Target | Year | Value | Scope | Baseline |
---|---|---|---|---|
Interim emissions reductionⓈCompany sustainability report | 2030 | 0.5 | 1&2&3 (value chain) | 2018 |
The company has initiated efforts to improve sustainability by focusing on Scope 3 CO2 emissions related to product manufacturing. They have also made strides in reducing resource consumption by manufacturing medicines exclusively in the EU, which saves resources and increases supply security. Additionally, the introduction of all-electric company cars in 2022 marks progress in reducing direct emissions. However, there is no quantitative data on the percentage reductions achieved or specific milestones related to a Net Zero Target.
Sustainability employees
2-3
ⓈThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.Fake Job Title 1
**************
Fake Job Title 2
**************
Disclaimer: The information provided by illuminem ("we", "us") is for general informational purposes only. All information on the pages is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy of any information on the pages. The information on the pages is either provided to us directly by the companies to which the information relates, or by third-party data providers, or derives from publicly available sources. In certain instances the information might be estimations based on limited information publicly available. Your reliance on any information provided on the pages is solely at your own risk. If you believe that any information is incorrect or in breach of your rights, please contact us.